MUMBAI, India, April 10 -- Intellectual Property India has published a patent application (202411072889 A) filed by Translational Health Science And Technology Institute, Faridabad, Haryana, on Sept. 29, 2024, for 'an engineered polypeptide complex for generating protective immune responses against monkey pox (mpox).'
Inventor(s) include Samal, Sweety; Ahmed, Shubbir; and Awasthi, Amit.
The application for the patent was published on April 10, under issue no. 15/2026.
According to the abstract released by the Intellectual Property India: "The present invention relates to the development of an engineered polypeptide complex, aimed at inducing protective antibody responses against the Monkey pox virus. The polypeptide complex is structured...